In the present study the extract of the secondary metabolites (E-G6-32) produced by the Curvularia sp. G6-32 endophyte (isolated from the medicinal plant Sapindus saponaria L.) and its biological activities were investigated. The antioxidant potential was confirmed by the DPPH (22.5%) and ABTS (62.7%) assays; the total phenolic compound content was 40 µg gallic acid equivalents/mg. The extract E-G6-32 displayed good inhibitory activity toward butyrylcholinesterase (BuChE; IC 50 = 110 ± 0.05 µg mL -1 ). The extract E-G6-32 was subjected to spectroscopic and mass spectrometry analyses ( 1 H and 13 C NMR, HMBC, HSQC, COSY, and MS/MS). Comparison with the literature data confirmed that (-)-asperpentyn (1) was a major component. Asperpentyn belongs to the epoxyquinone family that has attractive structural complexity, diverse functional groups, and a broad range of biological activities, including specific enzyme inhibitory activity. Our results suggest that Curvularia sp. G6-32 is a promising source of bioactive secondary metabolites that contain (-)-asperpentyn, which has potential pharmaceutical interest.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.